Tumor-derived PGE2 and TGF-β were shown to act in synergy to inhibit the production of IFN-α and TNF-α induced in TLR7- and TLR9-triggered pDCs, by decreasing TLR membrane expression or by blocking TLR downstream signaling (99). Here, TLR9 is linked to neoplasm.